These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 30036223)

  • 21. Prognostic factors and treatment outcome for patients with locally recurrent endometrial cancer.
    Sears JD; Greven KM; Hoen HM; Randall ME
    Cancer; 1994 Aug; 74(4):1303-8. PubMed ID: 8055452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Salvage of isolated vaginal recurrences in women with surgical stage I endometrial cancer: a multiinstitutional experience.
    Huh WK; Straughn JM; Mariani A; Podratz KC; Havrilesky LJ; Alvarez-Secord A; Gold MA; McMeekin DS; Modesitt S; Cooper AL; Powell MA; Mutch DG; Nag S; Alvarez RD; Cohn DE
    Int J Gynecol Cancer; 2007; 17(4):886-9. PubMed ID: 17309665
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Salvage high-dose-rate brachytherapy and external beam radiotherapy for isolated vaginal recurrences of endometrial cancer with no prior adjuvant therapy.
    Chapman CH; Maghsoudi K; Littell RD; Chen LM; Hsu IC
    Brachytherapy; 2017; 16(6):1152-1158. PubMed ID: 28802913
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The prognostic significance of age in surgically staged patients with Type II endometrial carcinoma.
    Vance S; Yechieli R; Cogan C; Hanna R; Munkarah A; Elshaikh MA
    Gynecol Oncol; 2012 Jul; 126(1):16-9. PubMed ID: 22507535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adjuvant therapy in stage III endometrial cancer: treatment outcomes and survival. a single-institution retrospective study.
    Kuku S; Williams M; McCormack M
    Int J Gynecol Cancer; 2013 Jul; 23(6):1056-64. PubMed ID: 23765205
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surgical stage, final grade, and survival of women with endometrial carcinoma whose preoperative endometrial biopsy shows well-differentiated tumors.
    Eltabbakh GH; Shamonki J; Mount SL
    Gynecol Oncol; 2005 Nov; 99(2):309-12. PubMed ID: 16005945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of body mass index on surgical outcomes and analysis of disease recurrence for patients with endometrial cancer undergoing robotic-assisted staging.
    Menderes G; Azodi M; Clark L; Xu X; Lu L; Ratner E; Schwartz PE; Rutherford TJ; Santin AD; Silasi DA
    Int J Gynecol Cancer; 2014 Jul; 24(6):1118-25. PubMed ID: 24927247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adjuvant treatment and analysis of failures in patients with high-risk FIGO Stage Ib-II endometrial cancer: an Italian multicenter retrospective study (CTF study).
    Gadducci A; Cosio S; Landoni F; Maggino T; Zola P; Sostegni B; Bellicini A; Fuso L; Cristofani R; Sartori E
    Gynecol Oncol; 2014 Jul; 134(1):29-35. PubMed ID: 24769176
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A multicenter evaluation of sequential multimodality therapy and clinical outcome for the treatment of advanced endometrial cancer.
    Secord AA; Havrilesky LJ; O'Malley DM; Bae-Jump V; Fleming ND; Broadwater G; Cohn DE; Gehrig PA
    Gynecol Oncol; 2009 Sep; 114(3):442-7. PubMed ID: 19560193
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictive factors of recurrence following adjuvant vaginal cuff brachytherapy alone for stage I endometrial cancer.
    Dunn EF; Geye H; Platta CS; Gondi V; Rose S; Bradley KA; Anderson BM
    Gynecol Oncol; 2014 Jun; 133(3):494-8. PubMed ID: 24657301
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patterns of recurrence in stage I endometrioid endometrial adenocarcinoma with lymphovascular space invasion.
    Simpkins F; Papadia A; Kunos C; Michener C; Frasure H; AbuShahin F; Mariani A; Bakkum-Gamez JN; Landrum L; Moore K; Thomas SG; Windhorn A; Rose PG
    Int J Gynecol Cancer; 2013 Jan; 23(1):98-104. PubMed ID: 23221731
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of management on the prognosis of pure uterine papillary serous cancer - a Taiwanese Gynecologic Oncology Group (TGOG) study.
    Huang CY; Tang YH; Chiang YC; Wang KL; Fu HC; Ke YM; Lau HY; Hsu KF; Wu CH; Cheng WF
    Gynecol Oncol; 2014 May; 133(2):221-8. PubMed ID: 24556064
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Minimally Invasive Compared With Open Hysterectomy in High-Risk Endometrial Cancer.
    Segarra-Vidal B; Dinoi G; Zorrilla-Vaca A; Mariani A; Student V; Garcia NA; Llueca Abella A; Ramirez PT
    Obstet Gynecol; 2021 Dec; 138(6):828-837. PubMed ID: 34735382
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adjuvant Therapy Use and Survival in Stage II Endometrial Cancer.
    Lester-Coll NH; Young MR; Park HS; Ratner ES; Litkouhi B; Damast S
    Int J Gynecol Cancer; 2017 Nov; 27(9):1904-1911. PubMed ID: 28763364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of vaginal brachytherapy in the treatment of surgical stage I papillary serous or clear cell endometrial cancer.
    Barney BM; Petersen IA; Mariani A; Dowdy SC; Bakkum-Gamez JN; Haddock MG
    Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):109-15. PubMed ID: 22543202
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pelvic control following external beam radiation for surgical stage I endometrial adenocarcinoma.
    Rush S; Gal D; Potters L; Bosworth J; Lovecchio J
    Int J Radiat Oncol Biol Phys; 1995 Nov; 33(4):851-4. PubMed ID: 7591893
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathologic stage I-II endometrial carcinoma in the elderly: radiotherapy indications and outcome.
    Citron JR; Sutton H; Yamada SD; Mehta N; Mundt AJ
    Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1432-8. PubMed ID: 15275729
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extended surgical staging for uterine papillary serous carcinoma: survival outcome of locoregional (Stage I-III) disease.
    Bristow RE; Asrari F; Trimble EL; Montz FJ
    Gynecol Oncol; 2001 May; 81(2):279-86. PubMed ID: 11330963
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oncologic Outcomes After Adjuvant Radiotherapy for Stage II Endometrial Carcinoma: A Korean Radiation Oncology Group Study (KROG 14-10).
    Jung J; Kim YS; Joo JH; Park W; Lee JH; Kim JH; Yoon WS; Lee SH; Eom KY; Kim YB
    Int J Gynecol Cancer; 2017 Sep; 27(7):1387-1392. PubMed ID: 28604455
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Whole-abdominal radiation in endometrial carcinoma: an analysis of toxicity, patterns of recurrence, and survival.
    Small W; Mahadevan A; Roland P; Vallow L; Zusag T; Fishman D; Massad S; Rademaker A; Kalapurakal JA; Chang S; Lurain J
    Cancer J; 2000; 6(6):394-400. PubMed ID: 11131490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.